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Abstract
During the last decades a large number of flavin-dependent monooxygenases have been isolated and studied. This has revealed
that flavoprotein monooxygenases are able to catalyze a remarkable wide variety of oxidative reactions such as regioselective
hydroxylations and enantioselective sulfoxidations. These oxidation reactions are often difficult, if not impossible, to be achieved
using chemical approaches. Analysis of the available genome sequences has indicated that many more flavoprotein monooxy-
genases exist and await biocatalytic exploration. Based on the known biochemical properties of a number of flavoprotein
monooxygenases and sequence and structural analyses, flavoprotein monooxygenases can be classified into six distinct flavopro-
tein monooxygenase subclasses. This review provides an inventory of known flavoprotein monooxygenases belonging to these
different enzyme subclasses. Furthermore, the biocatalytic potential of a selected number of flavoprotein monooxygenases is
highlighted.
© 2006 Elsevier B.V. All rights reserved.
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Efficient and specific insertion of one oxygen atom
into an organic substrate is a reaction that is difficult to
perform by chemical means. Although some catalysts
have been developed that are able to catalyze specific
oxygenations, the exquisite specificity of enzymes per-
forming monooxygenations (monooxygenases) is still
unequaled. This makes this class of enzymes (EC 1.13
and EC 1.14) of great interest for synthetic purposes.
In the last few decades a multitude of monooxyge-
nases have been discovered revealing a wide range
of reactivities and selectivities. Nevertheless, only a
small number have been explored for their synthetic
value. This is partly due to a limited availability of
enzymes, e.g. due to difficulties of enzyme expression
or isolation. Another practical problem associated with
biocatalytic applications involving monooxygenases is
the fact that most of these enzymes depend on expen-
sive coenzymes for their activities. Recent develop-
ments have alleviated some of these practical issues by,
e.g. employing improved expression systems, devel-
oping coenzyme regeneration systems or coenzyme
replacements. Also, in recent years several enzymes
have been discovered that can perform hydroxylations
while being coenzyme-independent. As a consequence
of these developments, effective practical biocatalytic
applications with monooxygenases are in reach.
The efforts in discovery and characterization of
monooxygenases have revealed that a number of differ-
ent types of enzymes have evolved in nature to catalyze
monooxygenation reactions. One of the best known
examples is the family of cytochrome P450 monooxy-
genases. These heme-containing enzymes (EC 1.14.13,
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EC 1.14.14 and EC 1.14.15) are relatively abundant,
occur in many isoforms, and have been shown to cat-
alyze a plethora of specific oxygenations. P450 genes
are abundant in eukaryotic genomes, e.g. 57 P450 genes
have been found in the human genome. Prokaryotic
genomes have been shown to be less rich in P450
monooxygenases. At present, only ∼300 P450 gene
homologs can be identified in the presently sequenced
bacterial genomes, corresponding to a frequency of just
one P450 gene in each prokaryotic genome.
The general catalytic mechanism of P450 monooxy-
genases has been elucidated revealing that the cat-
alyzed oxidation reaction is tightly coupled to substrate
binding. Only upon substrate binding the heme cofactor
can be reduced by a specific electron donor. The elec-
trons are typically delivered by an associated flavin-
containing reductase which in turn accepts electrons
from NAD(P)H. A striking catalytic feature of P450
enzymes is their ability to hydroxylate unactivated car-
bon atoms. Regioselective hydroxylations catalyzed by
P450 monooxygenases have been shown to be of value
to modify sterols and steroids.
Except for P450 monooxygenases, other
widespread monooxygenase classes are non-heme
monooxygenases (EC 1.14.16), copper-dependent
monooxygenases (EC 1.14.17 and EC 1.14.18), and
flavin-dependent monooxygenases (EC 1.13.12 and
EC 1.14.13). In recent years also a few new types
of monooxygenases have been identified that do not


















flavin-dependent monooxygenases is given with spe-
cial emphasis on members that display interesting bio-
catalytic properties. To provide a clear and systematic
overview, also a novel classification for all known flavo-
protein monooxygenases is proposed.
2. Flavoprotein monooxygenases
The concerted reaction between O2 and carbon in
organic compounds is spin-forbidden. Nevertheless,
a large number of enzymes have found a way to
use molecular oxygen as a substrate to oxygenate an
organic substrate. For such reactivity an enzyme has
to be able to activate molecular oxygen. To create a
species that transfers molecular oxygen, enzymes often
use a transition metal which may or may not be bound to
an organic cofactor, e.g. heme in P450 monooxygenase.
However, flavin-dependent monooxygenases employ a
purely organic cofactor for oxygenation reactions.
For reactivity with molecular oxygen a flavin cofac-
tor has to be in the reduced form. This electron rich
flavin intermediate is able to use molecular oxygen
as a substrate (Massey, 1994). Upon a one-electron
transfer from reduced flavin to oxygen, a complex is
formed of superoxide and the flavin radical. A subse-
quent spin inversion results in formation of reduced
oxygen (Ghisla and Massey, 1989). For most flavopro-
tein monooxygenases, a covalent adduct between the


















colyketide monooxygenase ActVA-Orf6, involved in
ctinorhodin biosynthesis in Streptomyces coelicolor
Sciara et al., 2003), and YgiN, a quinol monooxy-
enase from Escherichia coli (Adams and Jia, 2005),
xidize multiringed aromatic substrates without the
elp of any cofactor. Aclacinomycin-10-hydroxylase,
nvolved in anthracycline biosynthesis in Streptomyces
urpurascens, is again another monooxygenase type
s it depends on S-adenosyl-l-methionine as cofactor
Jansson et al., 2003; Jansson et al., 2005). The latter
typical monooxygenases appear to be relatively rare
s only a few examples have been identified so far.
A major and perhaps most ubiquitous group of
onooxygenases is formed by the flavin-dependent
onooxygenases. Flavin-dependent monooxygenases
ave been shown to cover a wide range of differ-
nt oxygenation reactions while being highly regio-
nd/or enantioselective. In this review an overview oftabilized, yielding a reactive C(4a)-hydroperoxyflavin
pecies (Fig. 1). Such a peroxyflavin is unstable and
ypically decays to form hydrogen peroxide and oxi-
ized flavin. However, flavoprotein monooxygenases
re able to stabilize this species in such a way that
t can oxygenate a substrate (Entsch and van Berkel,
995). Depending on the protonation state of the per-
xyflavin, either a nucleophilic or electrophilic attack
n the substrate is performed. As a result, a single
tom of molecular oxygen is incorporated into the
ubstrate, while the other oxygen atom is reduced to
ater (Fig. 1). Oxygenation reactions catalyzed by
avoprotein monooxygenases include amongst others
ydroxylations, epoxidations, Baeyer–Villiger oxida-
ions and sulfoxidations (Fig. 2). The specific type
f oxygenation and selectivity depends on the shape
nd chemical nature of the active site of each spe-
ific monooxygenase. However, based on sequence and
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Fig. 1. General mechanism of oxygenation reactions catalyzed by external flavoprotein monooxygenases.
structural homology several flavoprotein monooxyge-
nases subclasses can be discriminated revealing that
each subclass appears to cover only a limited range
of oxygenation reactions (see below). This suggests
that the type of oxygenation catalyzed by a flavopro-
tein monooxygenase is dictated to some extent by its
structural fold. Apparently, each fold favors catalysis
of certain oxygenation reactions.
As mentioned above, a flavin can only react with
molecular oxygen when it is in the reduced form. Most
monooxygenases equip the flavin cofactor with elec-
trons by consuming reduced coenzymes, NADH or
NADPH. These monooxygenases are called external
flavoprotein monooxygenases (EC 1.14.13). However,
some examples exist in which the flavin is reduced by
the substrate itself. E.g. in the case of lactate monooxy-
genase (EC 1.13.12.4) lactate is oxidized into pyruvate,
yielding reduced flavin (Sutton, 1957). In a subsequent
step the reduced flavin reacts with molecular oxygen
to oxidize the formed pyruvate into carbon dioxide and
Fig. 2. Reactions catalyzed by flavoprotein monooxygenases.
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acetate. These type of flavin-dependent monooxyge-
nases are called internal monooxygenases (EC 1.13.12)
and are extremely rare. Therefore, this review will only
focus on the group of external monooxygenases.
Except from the external and internal monooxy-
genases, there is another group of flavin-dependent
enzymes that can catalyze hydroxylation reactions.
However, in these enzymes the flavin is not directly
involved in the monooxygenation reaction but is
needed to oxidize the substrate. The oxygen atom that
is eventually incorporated into the oxidized (=acti-
vated) substrate is derived from water. Examples
of such flavoenzymes are vanillyl-alcohol oxidase
(EC 1.1.3.38) and p-cresol methyl hydroxylase (EC
1.17.99.1), which respectively, use molecular oxy-
gen and cytochrome c for flavin reoxidation. Both
these enzymes are able to hydroxylate a range of
alkylphenols in an enantioselective manner (Reeve et
al., 1990; Drijfhout et al., 1998; van den Heuvel et al.,
2000).
3. Classiﬁcation of ﬂavoprotein
monooxygenases
At present several hundreds of flavoenzymes have
been characterized and described. Most of these
flavoenzymes contain a non-covalently bound flavin as
prosthetic group, but there are some that contain cova-


















and (if available) structural data. An overview of the
resulting classification is given in Table 1. External
flavoprotein monooxygenases described to date can be
grouped in six subclasses: A–F. Discrimination is based
on sequence similarity and specific structural features
which are reflected in sequence similarity and the pres-
ence of specific protein sequence motifs. The typifying
characteristics and a description of some known mem-
bers belonging to each subclass are indicated in the next
paragraphs.
3.1. Class A ﬂavoprotein monooxygenases
3.1.1. General characteristics of class A
ﬂavoprotein monooxygenases
• Encoded by a single gene;
• contain a tightly bound FAD cofactor;
• depend on NADH or NADPH as coenzyme;
• NADP+ is released immediately upon flavin reduc-
tion;
• structurally composed of one dinucleotide binding
domain (Rossmann fold) binding FAD.
Class A monooxygenases can be NADPH or
NADH dependent. The C(4a)-hydroperoxyflavin is
the oxygenating flavin species, that performs an
electrophilic attack on the aromatic ring (Fig. 1).
Typical substrates are aromatic compounds that
contain an activating hydroxyl or amino group. This


















(xample, the above-mentioned vanillyl-alcohol oxi-
ase contains FAD linked to a histidine (de Jong et
l., 1992) while p-cresol methyl hydroxylase contains
AD linked to a tyrosine (McIntire et al., 1985). For
anillyl-alcohol oxidase it was shown that such a cova-
ent linkage is beneficial for catalysis as it enhances
he oxidative power of the flavin cofactor (Fraaije et
l., 1999). So far, all internal and external flavopro-
ein monooxygenases have been shown to bind the
avin cofactor, FAD or FMN, in a non-covalent manner
Fig. 3).
Classification of flavoenzymes has been done using
ifferent criteria, such as the type of chemical reaction
hat is catalyzed, the nature of the reducing and oxidiz-
ng substrates, homology in sequence or in topology of
D structures (Massey, 2000). In this review we have
lassified the group of external flavoprotein monooxy-
enases according to the last two criteria: sequencehat can also hydroxylate non-activated aliphatic
r aromatic compounds. Members of the class A
avoprotein monooxygenases usually are involved
n the microbial degradation of aromatic compounds
y ortho- or para hydroxylation of the aromatic ring
Moonen et al., 2002) and display a narrow substrate
pecificity. The prototype enzyme of this subclass is
-hydroxybenzoate 3-monooxygenase (EC 1.14.13.2)
rom Pseudomonas that has been studied comprehen-
ively (Entsch and van Berkel, 1995; Entsch et al.,
005). Other members are, e.g. 2-hydroxybiphenyl 3-
onooxygenase (EC 1.14.13.44) from Pseudomonas
zelaica (Suske et al., 1997), phenol 2-monooxygenase
EC 1.14.13.7) from Trichosporon cutaneum (Neujahr
nd Gaal, 1973), and salicylate 1-monooxygenase
EC 1.14.13.1) from Pseudomonas putida, the latter
eing the first characterized enzyme of this subclass
White-Stevens and Kamin, 1972). Monooxygenases
W.J.H. van Berkel et al. / Journal of Biotechnology 124 (2006) 670–689 675
Fig. 3. Structures of several prototype flavoprotein monooxygenases. (A) Structure of a class A flavoprotein monooxygenase: 4-hydroxybenzoate
3-monooxygenase from Pseudomonas ﬂuorescence. The FAD cofactor is shown in sticks. (B) Structure of a class B flavoprotein monooxygenase:
phenylacetone monooxygenase from Thermobiﬁda fusca. The FAD cofactor is shown in sticks. (C) Structure of a class C flavoprotein monooxy-
genase: alkanesulfonate monooxygenase from Escherichia coli. The FMN coenzyme was not bound in the crystalline enzyme preventing exact
localization of the active site. (D) Structure of a class F flavoprotein monooxygenase: tryptophan 7-halogenase from Pseudomonas ﬂuorescens.
The FAD coenzyme is shown in sticks.
belonging to this subclass have also been implicated
with the biosynthesis of ubiquinone (2-polyprenyl-
6-methoxyphenol 4-monooxygenase; Gin et al.,
2003) and modification of aromatic polyketides (e.g.
monooxygenases involved in biosynthesis or modifi-
cation of oxytetracycline (Yang et al., 2004), rifampin
(Andersen et al., 1997), mithramycin (Prado et al.,
1999), chromomycin (Menendez et al., 2004), auricin
(Novakova et al., 2005), and griseorhodin (Li and Piel,
2002)).
Except for hydroxylations, also enzymes belong-
ing to this subclass that catalyze epoxidations have
been described. A well-known example is squalene
monooxygenase (EC 1.14.99.7), a key enzyme in the
committed pathway for cholesterol biosynthesis in
eukaryotic cells. Squalene monooxygenase is bound to
the endoplasmic reticulum where it catalyzes the epox-
idation of squalene across a C–C double bond to yield
2,3-oxidosqualene. The enzyme is difficult to purify
and rather unstable. The soluble truncated recombinant







































































































































































































































































































































































































































































































































































































































































form of human squalene monooxygenase is dependent
upon NADPH-cytochrome P450 reductase for reduc-
ing equivalents, requires Triton X-100 for activity and
easily looses FAD (Laden et al., 2000).
Another class A flavoprotein epoxidase concerns
zeaxanthin epoxidase (EC 1.14.13.90). This plant
enzyme is located on the chloroplast stromal side of
the thylakoid membrane where it catalyzes the con-
version of zeaxanthin to antheraxanthin and violax-
anthin, an important reaction in the xanthophyll cycle
that protects the photosynthetic system against damage
by excess light. Zeaxanthin epoxidase has a speci-
ficity for carotenoids with a 3-hydroxy--cyclohexenyl
ring and requires besides from NADPH and FAD, also
ferredoxin-like reductives and specific lipids for activ-
ity (Bugos et al., 1998; Hieber et al., 2000).
Recently, a class A flavoprotein monooxygenase has
been discovered that is catalyzing a Baeyer–Villiger
oxidation (Prado et al., 1999; Gibson et al., 2005). This
bacterial enzyme (MtmOIV) is involved in the biosyn-
thesis of mithramycin, an anticancer drug and calcium-
lowering agent. As the monooxygenase has only been
discovered recently, little is known concerning its cat-
alytic potential and mode of action. It will be interest-
ing to elucidate how this class A monooxygenase has
evolved to catalyze a Baeyer-illiger oxidations as it has
been proposed that a flavin-catalyzed Baeyer–Villiger
reaction requires a peroxyflavin intermediate (see Sec-
tion 3.2) while class A flavoprotein monooxygenases

















oization of this monooxygenase has been reported
ecently (Wang et al., 2005). Elucidation of the crystal
tructure will shed more light on this mechanistic issue.
The 3-D structure has been solved for two represen-
atives of the class A flavoprotein monooxygenases:
-hydroxybenzoate 3-monooxygenase (Wierenga et
l., 1979; Schreuder et al., 1989) and phenol 2-
onooxygenase (Enroth et al., 1998). Both enzymes
re NADPH dependent and their sequences contain two
equence motifs for the FAD binding region. The N-
erminal GxGxxG sequence is indicative for the -
old (or Rossmann fold) that binds the ADP moiety of
AD (Wierenga et al., 1986). The amino acids of the
econd motif, GD, are in contact with the riboflavin
oiety of FAD (Eggink et al., 1990). Interestingly,
here is no distinct domain that binds the coenzyme
ADPH. This is in line with the fact that NADPH
nly forms a transient complex to reduce the flavin
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cofactor. The formed NADP+ is rapidly released. Nev-
ertheless, recognition of NADPH is very specific which
has triggered several groups to study the structural
basis of coenzyme recognition by 4-hydroxybenzoate
3-monooxygenase. Eppink et al. (1997) have described
an additional fingerprint sequence for this subclass
of monooxygenases. This fingerprint, containing a
highly conserved DG motif, is involved in binding
the pyrophosphate moieties of both FAD and NADPH.
Furthermore, recent mutagenesis and crystallographic
studies have revealed a plausible binding mode for
NADPH in PHBH (Eppink et al., 1999; Wang et al.,
2002).
3.1.2. EC members
EC 1.14.13.1 salicylate 1-monooxygenase; EC
1.14.13.2 (and EC 1.14.13.33) 4-hydroxybenzoate
3-monooxygenase; EC 1.14.13.3 4-hydroxyphenyl-
acetate 3-monooxygenase; EC 1.14.13.4 melilotate
hydroxylase; EC 1.14.13.5 imidazoleacetate 4-
monooxygenase; 1.14.13.6 orcinol hydroxylase;
EC 1.14.13.7 phenol hydroxylase; EC 1.14.13.9
kynurenine 3-monooxygenase; EC 1.14.13.10 2,6-
dihydroxypyridine 3-monooxygenase; EC 1.14.13.18
4-hydroxyphenylacetate 1-monooxygenase; EC
1.14.13.19 taxifolin 8-monooxygenase; EC 1.14.13.20
2,4-dichlorophenol 6-monooxygenase; EC 1.14.13.23
3-hydroxybenzoate 4-monooxygenase; EC 1.14.13.24

















cline monooxygenase (rendering microbes antibiotic-
resistant), a number of monooxygenases involved in
polyketide biosynthesis routes (including MtmOIV).
3.2. Class B ﬂavoprotein monooxygenases
3.2.1. General characteristics of class B
ﬂavoprotein monooxygenases
• Encoded by a single gene;
• contain a tightly bound FAD cofactor;
• depend on NADPH as coenzyme;
• keep the coenzyme NADPH/NADP+ bound during
catalysis;
• composed of two dinucleotide binding domains
(Rossmann fold) binding FAD and NADPH, respec-
tively.
This subclass is also referred to as multifunc-
tional flavin-containing monooxygenases as represen-
tatives of this subclass are able to oxidize both carbon
atoms and other (hetero)atoms. This subclass com-
prises three sequence-related flavoprotein monooxyge-
nase subfamilies (Fraaije et al., 2002):
- flavin-containing monooxygenases (FMOs);
- microbial N-hydroxylating monooxygenases
(NMOs);
- Baeyer–Villiger monooxygenases (Type I BVMOs).
All members of these three monooxygenase fam-

















H-aminobenzoate 1-monooxygenase; EC 1.14.13.35
nthranilate 3-monooxygenase; EC 1.14.13.38 anhy-
rotetracycline monooxygenase; EC 1.14.13.40
nthraniloyl-CoA monooxygenase; EC 1.14.13.44
-hydroxybiphenyl 3-monooxygenase; EC 1.14.13.50
entachlorophenol monooxygenase; EC 1.14.13.58
enzoyl-CoA 3-monooxygenase; EC 1.14.13.63
-hydroxyphenylacetate 6-monooxygenase; EC
.14.13.64 4-hydroxybenzoate 1-monooxygenase;






yphenol 4-monooxygenase, squalene monooxy-
enase, rifampin monooxygenase and oxytetracy-nd specific for NADPH. The protein sequences of
hese monooxygenases contain two Rossmann-fold
otifs indicative for two binding domains for FAD and
ADPH. In 2004 the first crystal structure for a mem-
er of this monooxygenase subclass was solved (see
elow; Malito et al., 2004).
FMOs (EC 1.14.13.8) were originally identified
n liver microsomes and named ‘mixed-function oxi-
ases’. The name of these enzymes was later changed
o flavin-containing monooxygenase (FMO; see for a
ecent review, Ziegler, 2002). FMOs are found in all
ammals and other eukaryotic organisms. In mam-
als and human several isoforms exist, each having
different substrate specificity and tissue localization.
ix FMO genes and five FMO pseudogenes have been
dentified in the human genome. FMO3 is the most
mportant isoform in the liver (Furnes et al., 2003;
ernandez et al., 2004). FMOs play an important role
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in detoxification of drugs and other xenobiotics in
the human body thereby complementing the activi-
ties of the cytochrome P450 system. The membrane-
associated enzymes catalyze the monooxygenation of
carbon-bound reactive heteroatoms: nitrogen, sulfur,
phosphorus, selenium, or iodine. In contrast to mam-
malian FMOs, yeast FMO does not oxidize nitrogen-
containing compounds but is only active with biolog-
ical thiols (Suh et al., 1996). It was shown that the
yeast enzyme is required for proper folding of disulfide-
containing proteins by generating an oxidizing envi-
ronment in the endoplasmatic reticulum (Suh et al.,
1999). In plants, an FMO was found to be involved in
the biosynthesis of auxin, a crucial hormone in plant
development (Zhao et al., 2001). Genome analysis
has revealed that FMO gene homologs are frequently
encountered in plant genomes, e.g. 29 gene homologs
are present in the genome of Arabidopsis thaliana.
Recently, the first bacterial FMO gene was cloned
(Choi et al., 2003). Overexpression and partial charac-
terization revealed that this enzyme is able to oxidize a
number of amines. Also indole is readily oxidized by
the enzyme as large amounts of indigo were formed
by the recombinant E. coli cells expressing the bacte-
rial FMO. Another bacterial FMO homolog has been
suggested to catalyze a Baeyer–Villiger oxidation to
form the polyketide pederin (Piel, 2002). In contrast to
eukaryotic genomes, searching the 309 presently avail-
able bacterial genomes using a FMO specific sequence

















tion: the Baeyer–Villiger oxidation of a ketone (or
aldehyde) to an ester or lactone. The prototype
of BVMOs is cyclohexanone monooxygenase (EC
1.14.13.22) from Acinetobacter sp. NCIB 9871. This
enzyme was originally isolated and characterized in
1976 (Donoghue et al., 1976). Extensive research
has shown that cyclohexanone monooxygenase car-
ries out Baeyer–Villiger oxidations on a wide variety
of cyclic ketones with exquisite chemo-, regio-, and
enantioselectivities (see for recent reviews, Stewart,
1998; Mihovilovic et al., 2002). The cyclohexanone
monooxygenase gene was cloned in 1988 (Chen et al.,
1988) and only 11 years later the next BVMO, steroid
monooxygenase (EC 1.14.13.54) from Rhodococcus
rhodochrous, was cloned (Morii et al., 1999). From
then on more sequences became steadily available
including the genes encoding 4-hydroxyacetophenone
monooxygenase (EC 1.14.13.84; Kamerbeek et al.,
2001), cyclododecanone monooxygenase (Kostichka
et al., 2001), cyclopentanone monooxygenase (EC
1.14.13.16; Iwaki et al., 2002) and ethionamide
monooxygenase (Fraaije et al., 2004). Some BVMO
sequences have been patented that are linked to detox-
ification of fungal toxins (e.g. US patent 6822140). A
BVMO acting on the monocyclic monoterpene ketones
1-hydroxy-2-oxolimonene, dihydrocarvone and men-
thone, was purified to homogeneity from Rhodococcus
erythropolis DCL14 (van der Werf, 2000). Also sev-
eral cyclohexanone monooxygenase homologs have

















(re relatively rare as only a few representatives can be
dentified.
Microbial NMOs, e.g. lysine N(6)-hydroxylase (EC
.14.13.59), catalyze the N-hydroxylation of long-
hain primary amines. They play a role in the biosyn-
hesis of various bacterial and fungal siderophores (low
olecular weight iron chelators). Cloning and sequenc-
ng of several NMO genes has revealed that they share
equence homology with FMOs (Stehr et al., 1998).
s for FMOs, NMOs specifically need NADPH to per-
orm catalysis. Limited biochemical data are available
or these enzymes, which is partly caused by their low
ffinity for FAD hindering mechanistic studies (Stehr
t al., 1999).
Several class B BVMOs, previously classified as
ype I BVMOs, have been cloned and character-
zed (Fraaije et al., 2002; Kamerbeek et al., 2003).
hese enzymes catalyze an atypical oxygenation reac-Kyte et al., 2004). By studying the catalytic properties
f a number of these cyclohexanone monooxygenase
omologs it was found that clustering of sequences
y sequence similarity coincides with stereopreference
Mihovilovic et al., 2005).
Sequence similarity analysis using a large set of
equences has shown that class B BVMOs can be iden-
ified using a specific protein sequence motif. This has
acilitated genome mining as BVMO-encoding genes
an be readily annotated using the sequence motif. By
his approach, a BVMO was identified in the genome
f the thermophilic soil bacterium Thermobiﬁda fusca.
his monooxygenase has been overexpressed and char-
cterized revealing activity towards aromatic com-
ounds while also aliphatic ketones are converted. As
he enzyme is very efficient in oxidizing phenylace-
one it has been named phenylacetone monooxygenase
EC 1.14.13.92; Fraaije et al., 2005). Phenylacetone
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monooxygenase represents the first class B monooxy-
genase for which the crystal structure has been deter-
mined (Malito et al., 2004). The structure is com-
posed of two Rossmann fold domains binding the FAD
cofactor and the NADPH coenzyme. As a result the
structure resembles to some extent other known flavo-
protein structures. The dinucleotide binding domains
are flanked by two helical domains which appear to be
unique for this type of monooxygenases. Close to the
reactive part of the flavin cofactor a conserved arginine
residue is located which is predicted to assist in forma-
tion and stabilization of the oxygenating peroxyflavin
intermediate. Replacing this residue has been shown to
eliminate oxygenating activity confirming the crucial
catalytic role of this arginine (Kamerbeek et al., 2004).
The availability of the phenylacetone monooxygenase
structure will facilitate enzyme redesign studies. An
example of structure inspired mutagenesis of pheny-
lacetone monooxygenase has been described recently
(see Section 4.5; Bocola et al., 2005).
3.2.2. EC members
EC 1.14.13.8 dimethylaniline monooxygenase
(eukaryotic FMO); EC 1.14.13.16 cyclopentanone
monooxygenase; EC 1.14.13.22 cyclohexanone mono-
oxygenase; EC 1.14.13.54 ketosteroid monooxy-
genase; EC 1.4.13.59 lysine N6-monooxygenase, EC
1.14.13.66 2-hydroxycyclohexanone 2-monooxygen-
ase; EC 1.14.13.84 4-hydroxyacetophenone monooxy-














different polypeptide chains that have different func-
tions: a reductase component carrying out the flavin
reduction and an oxygenase component oxidizing the
substrate by molecular oxygen. The reducing equiva-
lents needed for the oxygenation are transferred from
NAD(P)H to a flavin that is bound to the reductase
component. Subsequently, the reduced flavin is trans-
ferred to the oxygenase component. Upon reaction with
molecular oxygen, the peroxygenated flavin is formed
and the monooxygenation reaction takes place. While
only a few structures are known of the monooxyge-
nase components of these multi-component enzyme
systems, sequence information indicates that this group
can be dissected into four clearly distinct subclasses:
C–F (Table 1). Each of these subclasses appears to have
evolved to catalyze specific type of reactions and is dis-
cussed below.
3.4. Class C ﬂavoprotein monooxygenases
3.4.1. General characteristics of class C
ﬂavoprotein monooxygenases
• Encoded by multiple genes encoding one or two
monooxygenase components and a reductase com-
ponent;
• use reduced FMN as a coenzyme (generated by the
reductase);


















Indigo forming bacterial FMO, monocyclic





In addition to the single polypeptide flavoprotein
onooxygenases discussed in the previous two para-
raphs, also multi-component monooxygenases have
een discovered that use flavin as a coenzyme rather
han a cofactor. The variety in this group of monooxy-
enases is quite large concerning coenzyme use, coen-
yme specificity and sequence homology (Chaiyen et
l., 2001). Generally, these enzymes consist of twothe structural core of the monooxygenase subunit(s)
displays a TIM-barrel fold.
A number of monooxygenases have been described
hat belong to this subclass of flavoproteins monooxy-
enases on the basis of sequence homology. The
ost extensively studied representatives are bacterial
uciferases (EC 1.14.14.3). Bacterial luciferases are
ble to emit light upon oxidation of long-chain aliphatic
ldehydes. The luciferases are composed of a het-
rodimeric oxygenase component and require a reduc-
ase for delivery of reduced FMN. The two subunits of
he heterodimer are homologous in sequence and the
lucidated crystal structure of the oxygenase compo-
ent from Vibrio harveyi has revealed that they also
ave a similar structure, both exhibiting a TIM-barrel
old (Fisher et al., 1995; Baldwin et al., 1995). Nev-
rtheless, only one of the subunits contains an active
ite.
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Also several BVMOs belonging to this subclass
of flavoprotein monooxygenase have been described
(Taylor and Trudgill, 1986). The best-described
examples are from Pseudomonas putida ATCC 17453,
a strain that is able to grow on camphor (Trudgill,
1984). To degrade this compound, the bacterium
recruits three BVMOs (one of class B and two of
class C). Initial degradation is catalyzed by the
class C (Type II) BVMOs. The organism uses 2,5-
diketocamphane 1,2-monooxygenase (EC 1.14.15.2)
or 3,6-diketocamphane 1,6-monooxygenase (EC
1.14.15.2) for ring expansion of (+)- or (−)-camphor,
respectively. It was shown that the 2,5-diketocamphane
1,2-monooxygenase is built up by an oxygenase com-
ponent and an flavin reductase component (Taylor and
Trudgill, 1986). The oxygenase component consists of
two subunits of equal size and strongly binds one FMN
molecule closely resembling the above-mentioned
luciferases. In fact, bacterial luciferases have also been
classified as Type II BVMOs (Villa and Willetts, 1997)
based on the similar oligomeric structure and the fact
that luciferases are also able to catalyze a reaction
similar to a Baeyer–Villiger oxidation (Eckstein et
al., 1993). Consistent with this, it was shown that the
luciferases from Vibrio ﬁscheri and Photobacterium
phosphoreum perform Baeyer–Villiger reactions on
different ketones (Villa and Willetts, 1997). Neverthe-
less, the Type II BVMOs have never been reported to
emit light during catalysis.



















genase (Uetz et al., 1992; Knobel et al., 1996; Xu et al.,
1997).
3.4.2. EC members
EC 1.14.14.3 luciferase; EC 1.14.15.2 2,5-diketo-






3.5. Class D ﬂavoprotein monooxygenases
3.5.1. General characteristics of class D
ﬂavoprotein monooxygenases
• Encoded by two genes encoding a monooxygenase
and a reductase;
• use reduced FAD as a coenzyme (generated by the
reductase);
• the reductase can use NADPH and/or NADH as
coenzyme;
• no structure available, sequence homology suggests
a structural resemblance with the acyl-CoA dehy-
drogenase fold (mainly -helical).
The prototype enzyme for this subclass of monooxy-
genases is 4-hydroxyphenylacetate 3-monooxygenase
(EC 1.14.13.3) which has been identified in a number


















some other monooxygenases have been described
hat fit into this subclass of monooxygenases. E.
oli harbors an alkanesulfonate monooxygenase (EC
.14.14.5) by which it is able to utilize alkanesulfonates
s sulfur sources for growth. The enzyme depends
n reduced FMN for activity and is able to convert
wide range of alkanesulfonates. The crystal struc-
ure of alkanesulfonate monooxygenase has been eluci-
ated revealing a homotetrameric assembly of subunits
isplaying a TIM-barrel fold (Eichhorn et al., 2002).
inetic studies have suggested that efficient catalysis
equires formation of a complex between the monooxy-
enase, FMN and the reductase (Eichhorn et al., 1999).
ther class C monooxygenases have been found to be
nvolved in desulfurization pathways oxidizing diben-
othiophene into the corresponding sulfone. The initial
egradation of nitrilotriacetate, a widely applied chela-
or, is also catalyzed by a class C flavoprotein monooxy--monooxygenases come from E. coli W (Galan et al.,
000a; Prieto and Garcia, 1994) and Acinetobacter
aumanii (Chaiyen et al., 2001; Thotsaporn et al.,
004; Sucharitakul et al., 2005). Similar to class
flavoprotein monooxygenases, members of class
typically are active on aromatic substrates, e.g.
-hydroxyphenylacetate, phenol (Duffner et al.,
000; Kirchner et al., 2003; van den Heuvel et al.,
004) and 4-nitrophenol (Kadiyala and Spain, 1998).
urthermore, representatives of this subclass seem
o be restricted to only one type of oxygenation:
regioselective) hydroxylation. With 4-nitrophenol
onooxygenase, the enzyme catalyzes sequential
rtho- and para hydroxylations of which the latter
eaction is accompanied with nitrite release. With
,4,5-trichlorophenol monooxygenase (Xun, 1996;
isi and Xun, 2003), the para- and ortho hydroxylation
teps both are accompanied by elimination of chloride.
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With 2,4,6-trichlorophenol monooxygenase (Xun
and Webster, 2004), the enzyme catalyzes sequential
dechlorinations by oxidative and hydrolytic reactions.
Class D monooxygenases have also been shown to be
involved in hydroxylation of 4-chlorophenol (Nordin
et al., 2004), indole (Choi et al., 2004; Lim et al.,
2005) and polyketides (Brunke et al., 2001).
Although no structure is available for any of
these monooxygenases, a structural model of 4-
hydroxyphenylacetate-3-monooxygenase can be built
using the recently elucidated crystal structure of 4-
hydroxybutyryl-CoA dehydratase: a sequence related
flavoprotein (Martins et al., 2004). The structure
of 4-hydroxybutyryl-CoA dehydratase is similar
to known structures of flavin-containing acyl-CoA
dehydrogenases. This indicates that the acyl-CoA
dehydrogenase fold allows catalytic promiscuity as
several kinds of reactions can be catalysed by mem-
bers of this flavoprotein superfamily: hydroxylations,
dehydratations and oxidations.
3.5.2. EC members
EC 1.14.13.3 4-hydroxyphenylacetate monooxyge-















Pseudomonas sp. VLB120 (Otto et al., 2002). Sofar, a
very limited number of representatives of this flavopro-
tein monooxygenase subclass are known. In fact, only
some other styrene monooxygenases from pseudomon-
ads with similar characteristics have been reported
(Hartmans et al., 1990; Di Gennaro et al., 1999; Santos
et al., 2000; O’Leary et al., 2002; Kantz et al., 2005).
This low abundance is in agreement with genome anal-
ysis. Inspection of the available bacterial genomes
for the presence of additional class E flavoprotein
monooxygenases resulted in the identification of only
a few homologs (Table 1). This shows that class E
flavoprotein monooxygenases are relatively rare. Nev-
ertheless, we recently discovered a new member of this
flavoprotein monooxygenase subclass by metagenome
screening (M.W. Fraaije, personal communication).
All described styrene monooxygenases are highly
enantioselective in oxidizing styrene and some of its
derivatives. As enantiopure epoxides are interesting
building blocks in the fine-chemical industry, effort has
been put into developing efficient biocatalytic systems
based on this biocatalyst to produce styrene oxides (see
Section 4.1). Furthermore, some mechanistic details
have emerged in the last few years revealing that (1)
reduced FAD does not have to be actively delivered by
the reductase to the monooxygenase subunit, and (2)
the monooxygenase subunit is well able to form and
stabilize the peroxyflavin after binding reduced FAD
and reacting with molecular oxygen (Otto et al., 2002).














.6. Class E ﬂavoprotein monooxygenases
.6.1. General characteristics of class E
avoprotein monooxygenases
Encoded by two genes encoding a monooxygenase
and a reductase;
use reduced FAD as a coenzyme (generated by the
reductase);
the reductase can use NADPH and/or NADH as
coenzyme;
no structure is available, sequence analysis indicates
the presence of one dinucleotide binding domain
(Rossmann fold) thereby suggesting an evolutionary
link with the Class A flavoprotein monooxygenases
Another subclass of two-component monooxyge-
ases is represented by styrene monooxygenase fromomponent can stimulate catalysis of the monooxyge-
ase subunit. This phenomenon is rationalized by the
ypothesis that FAD can remain bound to the monooxy-
enase component via the ADP moiety of FAD while
he isoalloxazine part of the flavin binds to the active
ite of the reductase subunit (Kantz et al., 2005). The
alidity of this mechanism awaits the elucidation of the
rst styrene monooxygenase structure.
.6.2. Known member
Styrene monooxygenase.
.7. Class F ﬂavoprotein monooxygenases
.7.1. General characteristics of class F
avoprotein monooxygenases
Encoded by two genes encoding a monooxygenase
and a reductase;
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• use reduced FAD as a coenzyme (generated by the
reductase);
• the reductase can use NADPH and/or NADH as
coenzyme;
• two domain structure: one FAD binding domain
(Rossmann fold) and a helical domain.
Many halogenation reactions occurring in nature are
catalyzed by flavoenzymes. Members of this haloge-
nase family have been identified in the biosynthetic
pathways of antibiotics, antitumor agents and other
halometabolites (van Pee and Unversucht, 2003). One
of the best studied flavin-dependent halogenases is
tryptophan 7-halogenase (Keller et al., 2000; Yeh et
al., 2005). While the reaction catalyzed by this enzyme
does not result in formation of an oxygenated prod-
uct, the proposed catalytic mechanism is similar to
that of a flavoprotein monooxygenase. As for the
other two-component flavoprotein monooxygenases,
the monooxygenase component of the enzyme needs
reduced flavin (FAD), produced by a reductase, and
molecular oxygen for catalysis. A recent study has
shown that a rhodium organometallic complex can be
used for reduced FAD regeneration with formate as the
electron donor (Unversucht et al., 2005). This shows
that direct interaction with the reductase component is
not a prerequisite for catalysis.
Very recently, the structure of tryptophan 7-
halogenase has been determined revealing some



















the substrate is bound with respect to the end of the
tunnel. Apparently, these halogenases have combined
two chemical reactions in one protein scaffold in
which first the reduced flavin coenzyme is used to
form reactive HOCl. The latter compound is subse-
quently shuttled to another active site to react with the
organic substrate. As a consequence, the halide ion
can be regarded as substrate for the ‘monooxygenase’
half-reaction of these halogenases. The availability of
the halogenase structure will facilitate future structure-
inspired studies, e.g. it will be possible to modify
selectively the tryptophan binding site by which
regioselectivity and substrate specificity can be tuned.
3.7.2. Some known members
Tryptophan 7-halogenase, tryptophan 5-halogen-
ase, and ‘pyrrolyl’ halogenase (Dorrestein et al., 2005).
4. Biocatalysis with ﬂavin-dependent
monooxygenases
Regio- and/or enantioselective insertion of oxy-
gen is not straightforward to be accomplished
when using chemical techniques. Therefore, flavin-
dependent monooxygenases represent promising bio-
catalytic tools (Schmid et al., 2001a). This section
will discuss some of the monooxygenases that have
been shown to be of value for biocatalytic pro-
















gydroxybenzoate 3-monooxygenase (Dong et al.,
005). The tryptophan 7-halogenase structure is a
imer with each subunit forming a single domain.
esides from the conserved FAD binding module, the
alogenase subunit contains a helical substrate binding
odule. The structure is compatible with a ‘monooxy-
enase’ type of catalytic mechanism. Inspection of
he FAD-bound halogenase structure suggests that the
educed coenzyme will react with molecular oxygen
o form the hydroperoxyflavin intermediate. Based
n the location of the bound ligands/substrates, Cl−
nd tryptophan, it is suggested that a chloride ion
ill perform a nucleophilic attack on the hydroper-
xyflavin resulting in the formation of HOCl. This
ighly reactive molecule will travel through a 10 A˚
unnel to reach and halogenate the bound tryptophan
olecule. As a consequence of this mechanism the
egioselectivity of halogenation is dictated by the wayxplored for their biocatalytic properties, the monooxy-
enase examples illustrated below provide a good
iew on the catalytic capability of flavin-dependent
onooxygenases.
.1. Styrene monooxygenase: a selective
poxidation catalyst
Enantiopure styrene oxides are important build-
ng blocks for the pharmaceutical industry. A promis-
ng example of an enantioselective monooxygenase
s styrene monooxygenase from Pseudomonas sp.
LB120 (class E monooxygenase). This enzyme cat-
lyzes the conversion of styrene into (S)-styrene oxide
t an enantiomeric excess larger than 99% (Panke et
l., 1998). A recombinant E. coli expressing StyA and
tyB was developed (Panke et al., 2000) and this whole-
ell biocatalyst showed a broad substrate spectrum that
ives access to various chiral aryloxides (Schmid et al.,
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2001b). The system was successfully scaled-up and
it was possible to produce almost 400 g (S)-styrene
oxide at pilot-scale (30 L fed-batch bioconversion, two-
liquid phase system; Panke et al., 2002). Introduction
of an apolar organic solvent reduces toxic effects of
substrate and/or product and the use of whole cells
instead of an isolated biocatalyst has the advantage
of in vivo coenzyme regeneration. The same research
group that developed this whole cell biocatalyst also
designed a small-scale cell-free system. The only enzy-
matic component of this system is the monooxyge-
nase (StyA). The reductase component (StyB), NAD
and artificial formate dehydrogenase NADH regener-
ating system could be replaced by the organometal-
lic complex pentamethyl-cyclopentadienyl rhodium
bipyridine [Cp*Rh(bpy)(H2O)]2+. This redox-catalyst
receives electrons from the oxidation of formate to
carbon dioxide and is able to regenerate reduced
FAD directly. The epoxidation rate of this chemo-
enzymatic system was ∼70% of a fully enzymatic
reaction (Hollmann et al., 2003). The flavin coenzyme
can also be reduced by direct electrochemical reduction
using an electrode. In this way, the need for expensive
NAD(P)H coenzyme is circumvented facilitating bio-
catalytic applications.
4.2. Hydroxybiphenyl 3-monooxygenase: an
example of monooxygenase engineering
















tants. Until 70% of the sulfur content of diesel oil is pre-
sented as dibenzothiophenes. The conventional chem-
ical hydrodesulphurization process is not adequate
for complete removal of these compounds (Abbad-
Andaloussi et al., 2003). Therefore, biocatalytic pro-
cesses using flavoprotein monooxygenases may find
application in the desulfurization of fossil fuels (Gray
et al., 2003). Different approaches have been used to
engineer strains with improved desulfurization activity
exploiting the catalytic potential of dibenzothiophene
monooxygenases (class C monooxygenases). Overex-
pression of a flavin reductase in E. coli and P. putida
enhanced the overall rate of desulfurization as com-
pared to the use of wild-type strains (Galan et al.,
2000b; Reichmuth et al., 2000). To circumvent catabo-
lite repression of the monooxygenase gene cluster by
sulfonate, cysteines or methionines, these genes have
been placed under control of the tac promotor in vari-
ous Pseudomonas strains (Gallardo et al., 1997). Fur-
thermore, activities towards (highly) alkylated DBTs
have been improved using a chemostat approach
(Arensdorf et al., 2002) and gene shuffling (Coco et al.,
2001).
4.4. Cyclohexanone monooxygenase: a versatile
monooxygenase
From all the flavoprotein monooxygenases,
BVMOs have been studied most extensively for their

















hant E. coli strain expressing hydroxybiphenyl 3-
onooxygenase (class A monooxygenase) for the con-
ersion of 2-substituted phenols into 3-substituted cat-
chols, which are difficult to synthesize chemically.
uring production of 3-phenylcatechol, in situ product
emoval prevented toxic effects on the whole-cell bio-
atalyst. Isolated hydroxybiphenyl 3-monooxygenase
as been used in organic-aqueous reaction media
n combination with enzymatic coenzyme regenera-
ion (Lutz et al., 2002). Directed evolution has been
mployed to improve and broaden the substrate speci-
city and efficiency of this monooxygenase (Meyer et
l., 2002a,b).
.3. Monooxygenases involved in desulfurization
Combustion of sulfur-containing fuels such as diesel
eads to formation of sulfur oxides, which are air pollu-eal with a large number of different substrates while
xhibiting an exquisite enantio- and/or regioselectivity.
he most extensively studied BVMO is cyclohexanone
onooxygenase (class B monooxygenase). Currently,
ore than 100 substrates have been described for this
acterial enzyme (Mihovilovic et al., 2002). Nowa-
ays, also several cyclohexanone monooxygenase
omologs have been discovered and overexpressed
nabling comparative biocatalytic studies. This has
evealed that, while sequence identity among these
omologs can be high, the regioselectivity can
ary widely (Mihovilovic et al., 2005). Reetz et al.
2004a,b) have also shown by directed evolution that
nantioselectivity of cyclohexanone monooxygenase
an be significantly improved by altering only a single
mino acid.
A nice example of the applicability of a cyclo-
exanone monooxygenase was recently given by
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Hilker et al. (2005). They demonstrated that E.
coli cells expressing cyclohexanone monooxygenase
could be used to produce industrially relevant lac-
tones at kilogram scale. A high productivity for
the asymmetric Baeyer–Villiger oxidation of racemic
bicyclo[3.2.0]hept-2-en-6-one was obtained combin-
ing a resin-based in situ substrate feeding and product
removal (SFPR) methodology, a glycerol feed control,
and an improved oxygenation device. Both regioiso-
meric lactones [(−)-(1S,5R)-2 and (−)-(1R,5S)-3] were
obtained in nearly enantiopure form (ee > 98%) and
good yield. This novel technology opens the way to
further (industrial) upscaling of highly valuable (asym-
metric) monooxygenase reactions.
4.5. Phenylacetone monooxygenase: a new and
thermostable oxygenating biocatalyst
Phenylacetone monooxygenase (class B monooxy-
genase) was recently discovered by genome mining.
The phenylacetone monooxygenase gene was iden-
tified in the genome of the thermophilic bacterium
Thermobiﬁda fusca and as a result it displays an inter-
esting feature: it is relatively thermostable (Fraaije
et al., 2005). Biocatalytic conversions using previ-
ously discovered BVMOs often are hampered by the
instability of the respective monooxygenases. Except
for being thermostable, phenylacetone monooxyge-
nase also appears to be tolerant towards solvents



















type enzyme (Bocola et al., 2005). This shows that by
knowing the enzyme structure in atomic detail, it will
be possible to create novel enzyme variants with prop-
erties that are fine-tuned for biocatalytic purposes.
5. Concluding remarks
The inventory of known flavoprotein monooxyge-
nases described in this review shows that several pro-
tein scaffolds have been equipped with an oxygenating
capacity. Apparently, monooxygenases have evolved at
several occasions during evolution. The central reac-
tion in these enzymes is always the same: formation
of a peroxyflavin intermediate by reaction of reduced
flavin with molecular oxygen. Depending on the type
of monooxygenase, the flavin is reduced (1) in the
monooxygenase moiety itself, representing a tightly
bound flavin cofactor (subclasses A and B flavopro-
tein monooxygenases), alternatively (2) the flavin acts
as a coenzyme being reduced by a auxiliary flavin
reductase component after which the reduced flavin
is bound by the monooxygenase component (sub-
classes C–F). The final oxygenation reaction catalyzed
by each flavoprotein monooxygenase depends on the
microenvironment of the (peroxy)flavin bound to the
monooxygenase subunit, e.g. the protonation state of
the peroxy function can be modulated by amino acids
in the vicinity of the C(4a) of the flavin thereby reg-

















aent can greatly increase the enantioselectivity of the
nzyme when oxidizing sulfides. The substrate range
or this BVMO seems to be tuned towards aromatic
etones. However, also aromatic sulfides and sulfox-
des, aliphatic ketones, and organoboron compounds
re oxidized by the enzyme (Fraaije et al., 2005; de
onzalo et al., 2005a). The enzyme also displays excel-
ent enantioselective behaviour with a number of sul-
des and ketones. Furthermore, it has been shown
hat, as for styrene monooxygenase (see above), an
rganometallic complex can be used to replace the
oenzyme NADPH (de Gonzalo et al., 2005b). By
equence alignment with cyclohexanone monooxyge-
ase and inspection of the phenylacetone monooxy-
enase structure, several deletion mutants of pheny-
acetone monooxygenase have been prepared. As pre-
icted, these enzyme mutants are able to convert rel-
tively bulky substrates when compared with the wildhe peroxyflavin. Furthermore, the microenvironment
f the active site will determine which substrate will
e able to approach and bind in an appropriate posi-
ion. As a result each monooxygenase exhibits unique
atalytic properties. Each monooxygenase subclass
ppears to be biased towards specific oxygenation reac-
ions (Table 1), e.g. the class A monooxygenases pri-
arily catalyze hydroxylations and epoxidations while
he class F representatives only catalyze halogenations.
his suggests that each fold favors a certain type of
xidative activity.
This review illustrates that flavoprotein monooxy-
enases are very flexible with respect to the type of
xidations reactions that are catalyzed and the range of
ubstrate molecules that are accepted. It is expected that
uture research will even extend the range of reactions
hat can be catalyzed by flavoprotein monooxygenases
s these type of enzymes are frequently encountered in
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microbial genomes. Furthermore, recently developed
enzyme redesign methods allows fine tuning of selected
flavoprotein monooxygenases. Successful applications
of monooxygenases will depend on methodologies that
will facilitate efficient catalysis by, e.g. ensuring effec-
tive coenzyme recycling, oxygen transfer and product
recovery. By combining the enzyme discovery and
redesign efforts with process engineering, more appli-
cations that involve flavoprotein monooxygenases as
biocatalysts will emerge.
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